• EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis – 2021 updatehttps://pubmed.ncbi.nlm.nih.gov/34166721/
• Cost of non-alcoholic steatohepatitis in Europe and the USA: The GAIN study

https://www.researchgate.net/publication/342949234_Cost_of_non-alcoholic_steatohepatitis_in_Europe_and_the_USA_The_GAIN_study/link/5f0f1678a6fdcc3ed70846ce/download

• Fibroscan liver stiffness after anti-viral treatment for hepatitis C is independently associated with adverse outcomes

https://onlinelibrary.wiley.com/doi/abs/10.1111/apt.16092

• Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension

https://www.researchgate.net/publication/277777365_Expanding_consensus_in_portal_hypertension_Report_of_the_Baveno_VI_Consensus_Workshop_Stratifying_risk_and_individualizing_care_for_portal_hypertension

• Cost-comparison analysis of FIB-4, ELF and fibroscan in community pathways for non alcoholic fatty liver disease

https://bmcgastroenterol.biomedcentral.com/articles/10.1186/s12876-019-1039-4

• Porto-sinusoidal vascular disease: proposal and description of a novel entity

https://doi.org/10.1016/S2468-1253(19)30047-0

• A relação entre o fígado gordo e a diabetes

https://lifestyle.sapo.pt/saude/noticias-saude/artigos/a-relacao-entre-o-figado-gordo-e-a-diabetes